Calendar Eterna Therapeutics Inc.

Equities

ERNA

US1140822099

Market Closed - Nasdaq 02:00:01 04/05/2024 am IST 5-day change 1st Jan Change
1.855 USD +8.48% Intraday chart for Eterna Therapeutics Inc. +3.64% +3.34%

Chart calendar Eterna Therapeutics Inc.

ddb2751c2832cc2766a84.dLOqJdv6pvisFBL3NiyyloFgjpV0ZYEZ0-_FM5NhIS0.OOzeSq_OyJvfc0DGA2DGx9IjvdknM-Z_lLqDY9otc1Q6x5xil5bKyMRZJg~75a6d754f72572a8efc028c46a5856f2

Upcoming events on Eterna Therapeutics Inc.

No events available

Past events on Eterna Therapeutics Inc.

16/06/2023 08:30 pm Annual General Meeting
20/05/2023 12:30 am American Society of Gene Cell Therapy Meeting - Abstract & Poster Board Number: 1563
20/05/2023 12:30 am American Society of Gene Cell Therapy Meeting - Abstract & Poster Board Number: 1516
20/05/2023 12:30 am American Society of Gene Cell Therapy Meeting - Abstract & Poster Board Number: 1314
20/05/2023 12:30 am American Society of Gene & Cell Therapy Meeting - Abstract & Poster Board Number: 1262
19/05/2023 12:30 am American Society of Gene Cell Therapy Meeting - Abstract & Poster Board Number: 1103
19/05/2023 12:30 am American Society of Gene & Cell Therapy Meeting - Abstract & Poster Board Number: 1065
18/05/2023 06:30 am American Society of Gene Cell Therapy Meeting
18/05/2023 12:30 am American Society of Gene Cell Therapy Meeting - Abstract & Poster Board Number: 616
18/05/2023 12:30 am American Society of Gene Cell Therapy Meeting - Abstract & Poster Board Number: 563
17/10/2022 Reverse Split: 1 of 20
21/09/2022 08:30 pm Annual General Meeting
16/04/2022 01:45 am FY 2021 Earnings Release
09/12/2021 09:50 pm MedInvest Oncology Investor Conference
09/12/2021 03:10 am Benzinga Global SmallCAP Conference
09/11/2021 Q3 2021 Earnings Release
21/09/2021 02:00 am Business Update Call
20/08/2021 06:30 pm Annual General Meeting
20/08/2021 02:00 am Business Update Call
18/08/2021 09:30 pm SNN Virtual Investor Conference

Annual results

Fiscal PeriodDecember 2021
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
EBITDA
Released
Forecast
Spread
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-114
-111
-2.37%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-122
-120
-1.65%
Net income
Million USD
Released
Forecast
Spread
-122
-120
-1.66%
EPS
USD
Released
Forecast
Spread
-56,4
-56,0
-0.71%
Announcement Date15/04/22

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-9,11
-6,50
-40.08%
-6,30
-7,68
18.07%
-13,9
-6,65
-108.85%
-8,30
-6,55
-26.78%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-8,46
-6,50
-30.12%
-9,38
-6,37
-47.2%
-3,41
-6,65
48.75%
-7,31
-6,55
-11.62%
Net income
Million USD
Released
Forecast
Spread
-8,48
-6,50
-30.45%
-9,38
-6,37
-47.2%
-3,41
-6,65
48.75%
-7,32
-6,55
-11.69%
EPS
USD
Released
Forecast
Spread
0,00
-2,50
-
-3,40
-2,40
-41.67%
-1,20
-2,60
53.85%
-2,49
-2,20
-13.18%
Announcement Date15/04/2201/07/2211/08/2214/11/22

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ERNA Stock
  4. Calendar Eterna Therapeutics Inc.